Iris Barshack’s Post

I am delighted and proud to announce our new collaboration with Roche. Together, we are launching an innovative initiative that, for the first time, offers a comprehensive approach to integrating diverse algorithms for the diagnosis and personalized treatment of lung cancer. This collaboration aims to provide advanced diagnostic and treatment recommendations by leveraging multiple algorithms developed by Israeli startups, Roche’s development center, and the Digital Pathology Research Laboratory at Sheba Medical Center’s Institute of Pathology. All the algorithms will be seamlessly integrated into Roche’s Navify platform. This groundbreaking project marks the first time we are combining algorithms from various sources, each addressing unique aspects of the tumor analysis process. A heartfelt thank you to the incredible teams at Sheba’s Pathology Research Laboratory and Institute of Pathology for their dedication and hard wor! Thanks to the leadership of @Prof. Eyal Zimlichman, MD and Prof. Prof. Yitshak Kreiss To ARC team specially Shachar Orpaz Many thanks to our team at Pathology Institute : Alexander Loebel, PhD , @yoash Barak, @Efrat ofek, Yosef Molchanov , Chen Mayer , Many thanks for the close collaboration with Michael Rivers leader of Digital Pathology and to Roche Mostly to Avi Paley and Netanel Amichai of Roche Israel